Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Immunology, Immunotherapy : CII
|
September 23, 2025
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes
Giorgia Giordano, Alessandra Merlini, Federica Capozzi, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 25, 2013
Effective activity of cytokine-induced killer cells against autologous metastatic melanoma including cells with stemness features
Loretta Gammaitoni, Lidia Giraudo, Valeria Leuci, et al.
Cancer Immunology, Immunotherapy : CII
|
December 23, 2025
Correction: Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Immunology, Immunotherapy : CII
|
September 23, 2025
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes
Giorgia Giordano, Alessandra Merlini, Federica Capozzi, et al.
Cancer Immunology, Immunotherapy : CII
|
September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
Raffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST
Erika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2016
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Loretta Gammaitoni, Lidia Giraudo, Marco Macagno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 9, 2020
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes
Valeria Leuci, Chiara Donini, Giovanni Grignani, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 23, 2023
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Lidia Giraudo, Giulia Cattaneo, Loretta Gammaitoni, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells
Ramona Rotolo, Valeria Leuci, Chiara Donini, et al.
Page
of 3